What We Do

From pioneering research and development to ethical, code-compliant manufacturing and dynamic pharmaceutical marketing, Pharm-D Health Science seamlessly navigates the entire healthcare spectrum — from novel ingredients and consumer health products to pharmaceuticals, medical nutrition, devices and special needs solutions.
We are dedicated to building a comprehensive pharmaceutical and healthcare ecosystem that continues to expand across the Southeast Asia region.
We pride ourselves in maintaining exceptional standards throughout our operations, backed by advanced manufacturing facilities and research and development in providing localised health solutions to the public.

Research & Development

Our integrated capabilities span the entire product development cycle: from intellectual property (IP) creation to post-launch monitoring.

Research & Development

Our integrated capabilities span the entire product development cycle: from intellectual property (IP) creation to post-launch monitoring.

Manufacturing

Manufacturing

Strategic Partnerships

null

Market and Distribution Services

Who We Are

Based Malaysia and with a strong presence in Singapore, Pharm-D Health Science is a prominent specialty pharmaceutical and healthcare group of companies with over 20 years of excellence and innovation.
Pharm-D’s journey began with a group of dedicated pharmacists who recognized the urgent, unmet needs of niche, underserved patient groups.
From recognising and addressing these needs, Pharm-D has now expanded with a robust ecosystem spanning from manufacturing, research and development to patents and innovative solutions.
Our mission is to create healthcare products and provide supply chain solutions most trusted by healthcare professionals and the communities we are in.
0
+
years of expertise in pharmaceutical industry
0
+
vaccines and medicines in our pipeline
0
research publications in Southeast Asia
0
%
accuracy rate in healthcare diagnostics

Latest News & Updates

Discover More

理科大学 USM 与本地医药健康产业集团 Pharm-D Health Science Berhad 携手将屡获国际奖项的大马后生元科研创新推向市场

Press Releases

马来西亚理科大学工业技术学院副教授兼 Biotenova Sdn Bhd 联合创办人陈裕顺博士，是相关专利后生元技术的首席研究员。 吉隆坡讯 — 一项由马来西亚团队研发, 取材自猫山王榴莲及高丽菜等本地生物资源，并已取得清真认证的后生元（Postbiotic）科研技术近年来连接获得科学、创新及产业领域的认可与奖项。 这充分展现我国如何将本土资源转化为具全球应用价值的科研成果，以应对当今医疗健康、粮食体系及抗微生物药物耐药性 (Antimicrobial Resistance, AMR) 等挑战。 这项专利后生元科技由马来西亚理科大学与 Biotenova 共同研发，并授权予 Biotenova。Biotenova 为 Pharm-D Health Science Berhad（Pharm-D HS）旗下子公司，而 Pharm-D HS 则获授权担任其市场推广合作伙伴，推动相关科研成果走向商业化及市场应用。 该后生元科技迄今已获得多项殊荣，其中包括 2025年 SOBA（Star Outstanding Business Awards）卓越企业大奖 “最佳创新奖” 银奖，以及2026…

Read more
Discover More

Health for All with Science

We believe in inclusivity and science-based health solutions for everyone where every life, every diagnosis, every chapter of life, matter. We strive for better world and tomorrow where health is for all with science.
null

To create healthcare brands most trusted by healthcare professionals and the community

null

To make specialty medicines and nutrition for rare diseases accessible

null

To provide innovative solutions to pharmacy practice

null

To focus on research and development in providing localized solutions to the public

Career

Pharm-D Health Science Group values talents as paramount assets, cherishing human potential. Guided by unwavering ethical codes, our commitment is to consistently choose the right path.
Discover Jobs

We believe in the transformative power of people